FIELD: medicine.
SUBSTANCE: according to the invention pharmaceutical composition contains carbostyril derivative and serotonin reuptake inhibitor in pharmaceutically acceptable carrier. Carbostyril derivative is aripiprazole. Serotonin reuptake inhibitor can include fluoxetine, duloxetine, venlafaxine, milnaciprane, cytalopram, fluvoxamine, paroxetine, sertraline or escitalopram. According to the invention, the pharmaceutical composition can be used for treatment of phrenopathy patients, particularly suffering from depression or major depressive disorder.
EFFECT: according to the invention, the composition is characterised with synergetic action and can be applied in relatively small amounts, possesses lower by-effects and satisfactory safety characteristics.
36 cl, 8 dwg, 9 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CARBOSTYRIL DERIVATIVES AND SEROTONIN REUPTAKE INHIBITORS FOR TREATING PHRENOPATHIES | 2008 |
|
RU2389490C2 |
| DERIVATIVES OF CARBOSTYRIL AND STABILISERS OF MOOD FOR TREATMENT OF DISORDERS OF MOOD | 2004 |
|
RU2359675C2 |
| USING CANNABINOIDS COMBINED WITH ANTIPSYCHOTIC DRUG PREPARATION | 2008 |
|
RU2503448C2 |
| METHOD OF TREATING MAJOR DEPRESSION IN HUMAN | 2007 |
|
RU2445973C2 |
| ORGANIC COMPOUNDS | 2017 |
|
RU2733975C2 |
| ORGANIC COMPOUNDS | 2015 |
|
RU2785871C2 |
| ORGANIC COMPOUNDS | 2015 |
|
RU2728787C2 |
| METHODS OF USING PHENOXYPROPYLAMINE COMPOUNDS FOR TREATING DEPRESSION | 2014 |
|
RU2725112C2 |
| TREATING PSYCHOLOGICAL CONDITIONS WITH USING M-MUSCARINIC ANTAGONISTS | 2007 |
|
RU2477634C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF DEPRESSIONS | 2011 |
|
RU2475235C2 |
